The role of the CYP2B6 enzyme in drug metabolism is crucial, especially for individuals undergoing HIV treatment. CYP2B6 intermediate metabolizers, who possess a moderate level of enzyme activity due to genetic polymorphisms, face unique challenges when prescribed HIV medications metabolized by this enzyme, such as efavirenz. Efavirenz, a cornerstone antiretroviral drug, relies on CYP2B6 for […]
Abilify (aripiprazole) is one of the most commonly used atypical antipsychotics, treating diseases such as schizophrenia, bipolar disorder, and major depressive disorder. It works in the body by stabilizing neurotransmitters in the brain and subsequently managing symptoms associated with the condition. In patients who have epilepsy or take anti-epileptic drugs for their seizure condition, the […]
Pharmacogenomics (PGx) is transforming cardiovascular medicine by enabling personalized treatment approaches based on a patient’s genetic profile. In particular, PGx is helping cardiologists optimize the use of antiplatelet, anticoagulant, and beta-blocker therapies in patients with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI). While numerous critical aspects are involved in practical cardiovascular medicine […]
Tardive dyskinesia (TD) is a neurologic disorder involving involuntary, repetitive body movements that often result from long-term use of certain medications, particularly antipsychotics and other dopamine receptor-blocking agents. These movements may include the tongue, lips, face, trunk, and extremities and significantly impact a patient’s quality of life. Managing tardive dyskinesia requires a multifaceted approach, including […]
CYP2D6 Ultrarapid Metabolizer Symptoms: Can Pharmacogenomics Help? Cytochrome P450 2D6, commonly referred to as CYP2D6 is one of the key enzymes in the liver responsible for metabolizing approximately 25% of clinically used medications. Ultrarapid metabolizers have an increased rate of converting prodrugs, such as codeine and tramadol, into their active forms (morphine and O-desmethyltramadol, respectively). […]
Attention-Deficit/Hyperactivity Disorder (ADHD) affects millions in the United States. According to the CDC, approximately 6 million children between the ages of 3–17 have been diagnosed with ADHD, while millions of adults also live with this condition. Treating ADHD effectively often involves trial and error with various medications and dosages, leading to prolonged discomfort for patients […]
Adderall is a widely prescribed medication for individuals diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). While it can significantly improve focus, concentration, and impulse control, finding the right dosage often requires fine-tuning. If you or your child is already taking Adderall but there are no to little effects, mood instability, or forgetfulness you are experiencing, these may […]
Diabetes and post-traumatic stress disorder are two unrelated health issues. However, recent research studies have indicated an alarming relationship between the two medical conditions. PTSD is a mental illness that may be caused by exposure to or witnessing a traumatic event. It has been associated with the development and progression of diabetes. This blog post […]
Verzenio (abemaciclib) is a prescription medication used to treat advanced or metastatic breast cancer. Cancer cells grow and move to other organs, this medicine works by stopping the growth of cancer cells. It is a cyclin-dependent kinase (CDK) 4/6 inhibitor, meaning it blocks the activity of proteins that control cell growth, which can help slow […]
The complex post-traumatic stress disorder, referred to as C-PTSD, is more traumatic than the symptoms associated with a typical case of PTSD. The main difference is that PTSD is related to one traumatic event. At the same time, C-PTSD is developed from prolonged or repeated exposure to trauma, especially interpersonal trauma such as childhood abuse, […]